The Distressed Opportunity in Litigation Finance
Litigation finance is having an uncomfortable moment.
Significant write-downs at large funders, steep falls in listed share prices and reports of hedge funds acquiring funded claim portfolios for as little as 10 cents on the dollar have prompted a familiar round of questions about the future of the asset class. Is this simply a cyclical dislocation? Or does it reveal something more fundamental about the economics of litigation funding?
The answer is probably both less dramatic and more interesting than the loudest commentary suggests.
Critics of litigation finance have long argued that third-party funders distort the legal system by inflating claims, increasing litigation volumes and extracting value from disputes in which they have no legitimate role. Recent market events complicate that argument. If funders were routinely winning most of their cases and generating the 5x-plus returns sometimes alleged by opponents of the industry, their portfolios would not be available at distressed prices. They certainly would not be changing hands at a fraction of face value.
The more prosaic reality is that litigation finance remains a high-risk investment strategy. Cases that appear compelling at the point of underwriting can still be lost. Appeals can undo favourable outcomes. Timelines can extend far beyond initial expectations, reducing annualised returns even where the legal claim succeeds. Budgets can overrun. Recoveries can disappoint.
These are not aberrations. They are features of the asset class.
That point is often lost in the debate. Funders are frequently portrayed as indiscriminate backers of speculative litigation. In practice, most reject the vast majority of opportunities they review. The industry routinely declines more than 80 per cent of cases considered. Few credible funders would support a claim with only even prospects of success, let alone one below that threshold. Capital is typically reserved for matters with strong legal merits, solvent defendants and recoveries large enough to justify the risk.
The claims that are not funded rarely feature in political arguments about the industry. Yet they are central to understanding how the market actually operates.
None of this makes the current dislocation painless. Investors do not welcome write-downs, delayed realisations or secondary sales at distressed prices. But the existence of stress in the market should not be confused with evidence that the model is broken. Specialist asset classes often develop through periods in which pricing, underwriting discipline and portfolio construction are tested.
Litigation finance is no different.
The current environment is likely to separate those who understand the complexity of the risk from those who treated the asset class as a simple source of uncorrelated yield. Diversification matters. Duration matters. Budget control matters. So do enforcement risk, damages analysis and the ability to withstand long periods without liquidity.
For investors, the lesson is not that litigation finance should be avoided. It is that manager selection matters more than ever. Distress in existing portfolios may create opportunities for those with capital, patience and underwriting discipline. But those opportunities are unlikely to reward indiscriminate enthusiasm.
At Erso we have always viewed litigation finance as an asset class that rewards rigour rather than scale for its own sake. The present market is creating genuine opportunities, but they come with genuine risks. The right response is not to retreat from the sector, nor to assume that all claims can be bought cheaply and monetised easily. It is to apply careful judgment to each case, each portfolio and each pricing decision.
The broader question for the industry is whether this period produces a more disciplined market. Distressed portfolios should become the exception, not a recurring feature. That will require realistic assumptions about case outcomes, timelines and recoveries. It will also require restraint as new capital enters the sector.
Too much money chasing too few high-quality claims would create its own problem. The next test for litigation finance is not only whether investors return. It is whether the industry can absorb that capital without weakening the standards that make the asset class investable in the first place.